Sentence examples for risky litigation from inspiring English sources

When a big merger broke down in years past, as they often did, the last thing corporate managers wanted was costly, distracting, time-consuming, risky litigation.

"Michael [Gove] was politely asked to back off and see if a compromise deal could be found rather than risk tens of millions of pounds on risky litigation," a Treasury source said.

In his book, Winkler describes how the NRA, hewing to its policy of avoiding risky litigation, made it clear to Gura and to Bob Levy, a senior fellow at the libertarian Cato Institute who financed the Heller case, that it did not support their plan.

Also, Merck, although risky given the litigation surrounding its Vioxx product, has speculative appeal at these depressed prices.

"Small businesses are at a disadvantage when this happens because litigation is expensive, risky and takes an owner's mind off the business".

In any event, cash is precious in this downturn, and litigation is both costly and risky.

Understanding the details of relevant laws can help you spot whether a campaign would be in potential breach of regulations; it can save time by avoiding going down risky paths; and minimise the chances of litigation in the future.

"If any of the information at issue is relevant to any of those then they would have a problem doing that because they are effectively going to obstruct or impede that investigation or litigation so it would be legally risky to do that unless they know that it's not related to those things," Robbins continues.

Senator Nia Gill, a Democrat from Montclair, said she was voting against Mr. Kwon precisely because it was too risky to confirm someone "who a year before was part of the litigation team to advance Governor Christie's agenda" and who would have to be trusted to recuse himself when issues he worked on came before the Supreme Court.

The path ahead for the litigation in all three cases is long, difficult to predict and risky, legal experts say.

Consumer products generally are steadier and less risky than pharmaceuticals, with lower research and development costs, fewer regulatory demands, lower litigation costs and less impact from generic competition.